Eco (booth No. R29) will soon appear at the 23rd China Biologics Conference
Share
Conference Introduction:
The 23rd China Biologics Conference is an annual key event in the Chinese biologics industry, aimed at promoting academic exchanges, technological innovation, and industry cooperation in the field of biologics.
The conference typically includes:
Academic Presentations: Renowned experts and scholars from China and abroad discuss the latest research advancements, technological trends, and hot topics in the biologics field.
Exhibition Displays: Biologics companies showcase their latest products, technologies, and services, providing a platform for industry exchange and cooperation.
Specialized Forums: Specialized forums focus on areas such as vaccines, blood products, and cell therapy, exploring in-depth the opportunities and challenges facing industry development.
Project Matchmaking: Organizing activities such as project roadshows and technology transfers to facilitate collaboration between industry, academia, and research institutions, promoting the transformation of research outcomes
Shanghai Eco Polymer Sci.&tech. Co., Ltd. was founded in 2009 and is headquartered in Shanghai Zhangjiang Modern Medical Equipment Park. It has a 2,000-square-meter R&D center in Lingang, Shanghai, and 1,500-square-meter and 7,000-square-meter Class 10,000 cleanroom factories in Zhangjiang and Taizhou, Zhejiang respectively. Additionally, a 13,000-square-meter cleanroom factory is under construction.
Ecopoly has subsidiaries in Suzhou and San Francisco, focusing on R&D and production of medical catheter consumables and membrane materials for the medical device and biopharmaceutical fields. It provides professional product solutions to global customers.
Ecopoly is renowned for its outstanding technological innovation and service awareness, holding certifications such as "High-Tech Enterprise," "ISO13485," and "Class 10,000 Cleanrooms." By July 2023, it had obtained 33 patents for inventions and utility models.
As a leading global provider of specialized technical solutions in medical catheters and membrane materials, Ecopoly has secured tens of millions in Series A funding from prominent funds such as YuanBio Ventures, Qiming Venture Partners, CICC Capital, Blue Bay Capital, and over 100 million in Series B funding.
Visit our website at www.ecopolytec.com.
